Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Mary Anne Dellva, MS
JCP
Original Research
Efficacy Outcomes From 3 Clinical Trials of Edivoxetine as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
May 25, 2016
Susan G. Ball
,
Margaret B. Ferguson
,
James M. Martinez
, et al
JCP
Original Research
Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation
February 9, 2010
Stephen R. Marder
,
Sebastian Sorsaburu
,
Eduardo Dunayevich
, et al
JCP
Original Research
Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder
August 15, 2007
Eduardo Dunayevich
,
Haya Ascher-Svanum
,
Fangyi Zhao
, et al
JCP
Original Research
Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis
March 1, 2001
Jöerg Czekalla
,
Charles M. Beasley, Jr.
,
Mary Anne Dellva
, et al
JCP
Original Research
Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia
May 15, 1997
Pierre V. Tran
,
Mary Anne Dellva
,
Gary D. Tollefson
, et al
